Skip to main content
Clinical Trials/JPRN-UMIN000008451
JPRN-UMIN000008451Completed未知

Randomized Controlled Trial of mirtazapine vs lithium as augmentation after SSRI/SNRI failure. - Mirtazapin Effectiveness for Treatment Resistant depressION (METRION)

Kansai Medical University Department of Neuropsychiatry0 sites50 target enrollmentStarted: July 17, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
25years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Subjects with clinically significant unstable medical illness, pregnancy, a principal psychiatric diagnosis other than major depression, a history of substance abuse or dependence active within the previous 6 months, and electroconvulsive therapy within the previous 6 months were excluded. Subjects with axis I disorder other than major depressive disorder and personality disorder was also excluded.

Investigators

Sponsor
Kansai Medical University Department of Neuropsychiatry

Similar Trials